India’s First Home-Grown Cervical Cancer Vaccine To Be Available In The Market This Month

The Serum Institute of India’s (SII) quadrivalent human papillomavirus (qHPV) vaccine ‘CERVAVAC’ will be available in…

Explained: As India Unveils SII’s CERVAVAC, Know How Cervical Cancer Vaccines Work

Pune-based pharmaceutical firm Serum Institute of India (SII) will soon launch CERVAVAC, India’s first indigenously developed…

Cervical Cancer Vaccine To Be Available In Few Months, To Be Priced Between Rs 200-400: SII CEO

Serum Institute of India’s (SII’s) Quadrivalent Human Papillomavirus vaccine (qHPV) against cervical cancer was launched in…

SII To Launch India’s First Indigenously Developed Vaccine Against Cervical Cancer Tomorrow

Pune-based pharmaceutical firm Serum Institute of India (SII) and the Department of Biotechnology (DBT) will launch…

India’s first indigenously developed vaccine against cervical cancer to be launched tomorrow

Image Source : PTI/REPRESENTATIVE India’s first vaccine against cervical cancer to come on September 1 Highlights…

Govt Panel Gives Nod To Serum Institute’s qHPV Vaccine For Cervical Cancer Patients Aged 9-26 Y

The Drugs Controller General of India’s (DCGI) Subject Expert Committee (SEC) has recommended the quadrivalent human…